Clinical evaluation of the CF(12)m cystic fibrosis DNA diagnostic kit

Clinical Chemistry

Volumn 44, Issue 6, 1998, Pages 1346-1348

  Houdayer, Claude ^a   Cazeneuve, Cecile ^b   Cougoureux, Emmanuel ^a   Magnier, Catherine ^a   Tredano, Mohammed ^a   Aymard, Pierre ^a   Goossens, Michel ^b   Feldmann, Delphine ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE;

EID: 0031747469     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.6.1346     Document Type: Article

References (14)

1. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WL, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1990:3799-876.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
3. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-16.
4. Kazazian HH. Population variation of common cystic fibrosis mutations. Hum Mutat 1994;4:167-77.
5. Feldmann D, Sardet A, Cougoureux E, Fontaine JL, Tournier G, Aymard P. Identification of 3 novel mutations in the CFTR gene, R117P, ΔD192 and 3121+1G→A in four French patients. Hum Mutat 1998 (Suppl 1):S78-80.
6. Robertson NH, Weston SL, Kelly SJ, Duxbury NJ, Pearce SR, Elsmore P, et al. The development and validation of a screening test for 12 common mutations of the cystic fibrosis CFTR gene. Eur Respir J (in press).
7. Costes B, Fanen P, Goossens M, Ghanem N. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations. Hum Mutat 1993;2:185-91.
8. Avidor B, Zakut H, Kerem B. Simple, rapid nonradioactive method to detect major cystic fibrosis mutations in Ashkenazi Jews. Clin Chem 1996;42: 103-5.
9. Gilfillan A, Axton R, Brock DJH. Mass screening for cystic fibrosis heterozygotes: two assays systems compared. Clin Chem 1994;40:197-9.
10. Sanguiolo F, Maceratesi P, Mesoraca A, Botta A, Cavicchini A, Novelli G, Dallapiccola B. Simultaneous detection of ΔF508, G542X, NI303K, G55ID and 1717-IG→A cystic fibrosis alleles by a multiplex DNA enzyme immunoassay. Int J Clin Lab Res 1995;25:142-5.
11. Ferrie RM, Schwarz MJ, Robertson NH, Vaudin S, Super M, Malone G, Little S. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet 1992;51:251-62.
12. Williamson R. Universal community carrier screening for cystic fibrosis? Nat Genet 1993;3:195-201.
13. Wilcken B, Wiley V, Sherry G, Bayliss U. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies. J Pediat 1995;127:965-70.
14. Iovanna JL, Ferec C, Sarles J, Dagorn JC. The pancreatitis-associated protein (PAP). A new candidate for neonatal screening of cystic fibrosis. C R Acad Sci III 1994;317:561-4.